Redwood City, CA, United States of America

Thorsten A Kirschberg

USPTO Granted Patents = 42 (Patent Applications = 19)

CIPO Patents = 4 (Patent Applications = 9)

EPO Patents = 10 (Patent Applications = 20)

Average Co-Inventor Count = 9.5

ph-index = 15

Forward Citations = 683(Granted Patents)

Location History:

Belmont, CA (US) (2008 - 2012)
Foster City, CA (US) (2012)
Redwood City, CA (US) (2013 - 2018)
San Carlos, CA (US) (2018 - 2024)

Company Filing History:

28 out of 923

Gilead Sciences, Inc.

Gilead Pharmasset LLC

patents

4. 3 out of 11

Terns Pharmaceuticals, Inc.

Korea Research Institute of Chemical Technology

patents

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Leukemia Treatments

Thyroid Hormone Receptor Agonists

Tyrosine Kinase Inhibitors

Crystalline Compounds

Pyrrolizine Compounds

FLT3 Inhibitors

COT Modulators

Antiviral Compounds

Phosphonate Analogs

HIV Reverse Transcriptase Inhibitors

Anti-Cancer Compounds

Immuno-Modulatory Activity

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12454524 - (r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide, or a pharmaceutically acceptable salt or tautomer thereof, for treating certain leukemias (2025-10-28),

2. 12398127 - Thyroid hormone receptor beta agonist compounds (2025-08-26),

3. 12240835 - Substituted benzamides as intermediates in the synthesis of inhibitors of tyrosine kinase enzymatic activity (2025-03-04),

4. 12215113 - Crystalline forms of N[4[4-(4-Morpholinyl)-7H-Pyrrolo[2-3-D]Pyrimidin-6-yl]Phenyl]-4-[[3(R)-[(1-Oxo-2-Protein-1-yl)Amino]-1-Piperidinyl]Methyl]2-Pyridinecarboxamide] (2025-02-04),

5. 12161625 - Substituted pyrrolizine compounds and uses thereof (2024-12-10),

6. 11945785 - Pyrazine compounds as inhibitors of FLT3 (2024-04-02),

7. 11905299 - Cot modulators and methods of use thereof (2024-02-20),

8. 11203587 - Thyroid hormone receptor beta agonist compounds (2021-12-21),

9. 11066414 - Cot modulators and methods of use thereof (2021-07-20),

10. 10919911 - Tricyclic ASK1 inhibitors (2021-02-16),

11. 10889571 - Substituted benzoimidazoles and imidazo[4,5-c]pyridines for treating certain leukemias (2021-01-12),

12. 10874640 - Substituted pyrrolizine compounds and uses thereof (2020-12-29),

13. 10800767 - Thyroid hormone receptor beta agonist compounds (2020-10-13),

14. 10577352 - Cot modulators and methods of use thereof (2020-03-03),

15. 10328053 - Substituted pyrrolizine compounds and uses thereof (2019-06-25),

Title: The Innovative Journey of Thorsten A Kirschberg

Introduction: Thorsten A Kirschberg is a renowned inventor based in Redwood City, CA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Thorsten A Kirschberg holds several patents in the areas of technology, healthcare, and sustainability, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Thorsten A Kirschberg has worked with leading companies to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Thorsten A Kirschberg has collaborated with top researchers, engineers, and scientists to bring his innovative ideas to life, resulting in impactful inventions.

Conclusion: Thorsten A Kirschberg's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.